mci 9038 has been researched along with Inflammation in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Horani, RA; Aliter, KF | 1 |
| Bulani, Y; Sharma, SS | 1 |
| Chen, H; Cui, G; Hu, J; Hua, F; Jin, P; Jing, J; Liu, B; Ye, X; Zhao, H; Zhao, Q; Zhu, J; Zuo, T | 1 |
| Chen, JL; Chen, W; Fan, RM; Han, C; Jiao, S; Li, G; Wang, CM; Xia, XP; Yao, ST; Zeng, YC | 1 |
| Chakraborty, AK; Griffin, DK; Sheppard, JA; Warkentin, TE | 1 |
| Copple, BL; Cui, W; Kassel, KM; Luyendyk, JP; Sullivan, BP | 1 |
| Kubo, Y; Kudo, A; Kurose, A; Ogasawara, K; Ogawa, A; Sawai, T; Suzuki, M; Suzuki, T; Yoshida, K | 1 |
| Kobayashi, H; Koide, M; Matsuo, M; Matsuo, T; Sakamoto, S; Shimamo, C; Suzuki, S | 1 |
1 review(s) available for mci 9038 and Inflammation
| Article | Year |
|---|---|
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19.
Topics: Antithrombins; Arginine; Blood Coagulation; COVID-19; COVID-19 Drug Treatment; Drug Development; Humans; Inflammation; Pipecolic Acids; SARS-CoV-2; Sulfonamides | 2021 |
1 trial(s) available for mci 9038 and Inflammation
| Article | Year |
|---|---|
Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Topics: Aged; alpha-2-Antiplasmin; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombin III; Arginine; Aspirin; Biomarkers; Combined Modality Therapy; Endothelium, Vascular; Female; Fibrinolysin; Fibrinolytic Agents; Hemostasis; Heparin; Heparin Cofactor II; Humans; Inflammation; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Pipecolic Acids; Plasminogen Activator Inhibitor 1; Plasminogen Activator Inhibitor 2; Platelet Count; Prothrombin; Sulfonamides; Tissue Plasminogen Activator; von Willebrand Factor | 2000 |
6 other study(ies) available for mci 9038 and Inflammation
| Article | Year |
|---|---|
Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Heart; Inflammation; Male; Myocardium; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Receptors, Proteinase-Activated; Signal Transduction; Sulfonamides | 2017 |
ROCK mediates the inflammatory response in thrombin induced microglia.
Topics: Amides; Animals; Antithrombins; Arginine; Cells, Cultured; Cerebral Cortex; Fluorescein; Fluorescent Dyes; Inflammation; Microglia; Microspheres; Nitric Oxide; Phagocytosis; Pipecolic Acids; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Sulfonamides; Thrombin; Tumor Necrosis Factor-alpha | 2013 |
Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage.
Topics: Animals; Apoptosis; Arginine; Brain Edema; Cerebral Hemorrhage; Complement C5a; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Peptides, Cyclic; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptor, Anaphylatoxin C5a; RNA, Messenger; Stroke; Sulfonamides; Tubulin | 2014 |
The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome.
Topics: Aged; Arginine; Female; Fondaparinux; Heparin; Humans; Immunoenzyme Techniques; Inflammation; Pipecolic Acids; Platelet Factor 4; Polysaccharides; Sulfonamides; Syndrome; Thrombocytopenia; Treatment Outcome | 2012 |
Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.
Topics: Animals; Arginine; Chemokine CCL2; Chemokine CXCL2; Collagen; Diet; Fatty Liver; Feeding Behavior; Gene Expression Regulation; Inflammation; Intercellular Adhesion Molecule-1; Lipid Metabolism; Lipids; Liver; Liver Cirrhosis; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pipecolic Acids; Receptors, LDL; RNA, Messenger; Sulfonamides; Thrombin; Weight Gain | 2012 |
Thrombin inhibitor ameliorates secondary damage in rat brain injury: suppression of inflammatory cells and vimentin-positive astrocytes.
Topics: Animals; Antithrombins; Arginine; Astrocytes; Brain Injuries; Glial Fibrillary Acidic Protein; Inflammation; Macrophages; Male; Monocytes; Neutrophils; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Vimentin | 2000 |